ARTICLE | Company News
Cortex Pharmaceuticals, NV Organon deal
February 5, 2001 8:00 AM UTC
Under a 1999 agreement, Organon exercised its option to obtain an exclusive worldwide license to CORX’s Ampakine compounds that modulate the activity of the AMPA neurotransmitter receptor for use in t...